Literature DB >> 11045374

Molecular biology of human immunodeficiency virus type 1.

W K Wang1, M Y Chen, C Y Chuang, K T Jeang, L M Huang.   

Abstract

Since the discovery of human immunodeficiency virus (HIV) as the etiologic agent of acquired immune deficiency syndrome (AIDS) more than a decade ago, tremendous progress has been made in various aspects of this virus and its interplay with the host immune system. The advent of potent combination therapy has made it possible to achieve effective and durable control of HIV-1 replication in vivo, yet the persistence of the latent reservoirs pose a new challenge. The recent identifications of several cellular proteins interacting with different viral gene products have not only shed new insights into our understanding of the HIV-1 and the host cell biology, but also provided the bases for developing novel strategies to block HIV-1 replication. It is from this perspective that we review the current understanding of the molecular mechanisms governing the HIV-1 life cycle.

Entities:  

Mesh:

Year:  2000        PMID: 11045374

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  9 in total

1.  Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.

Authors:  James P McGettigan; Kristin Naper; Jan Orenstein; Martin Koser; Philip M McKenna; Matthias J Schnell
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

2.  Stability of HIV Frameshift Site RNA Correlates with Frameshift Efficiency and Decreased Virus Infectivity.

Authors:  Pablo Garcia-Miranda; Jordan T Becker; Bayleigh E Benner; Alexander Blume; Nathan M Sherer; Samuel E Butcher
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

3.  Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?

Authors:  Abraham Joseph Kandathil; Rajesh Kannangai; Oriapadickal Cherian Abraham; Susanne Alexander Pulimood; Gopalan Sridharan
Journal:  Bioinformation       Date:  2009-12-12

4.  A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.

Authors:  Melody R Davis; Jiyang Jiang; Jing Zhou; Eric O Freed; Christopher Aiken
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 Env.

Authors:  Vijay Sivaraman; Liguo Zhang; Eric G Meissner; Jerry L Jeffrey; Lishan Su
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

6.  Cleavage, a real turn-off? HIV-mediated proteolysis of PABP1.

Authors:  Brian Collier; Nicola K Gray
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

7.  Next-generation sequencing reveals HIV-1-mediated suppression of T cell activation and RNA processing and regulation of noncoding RNA expression in a CD4+ T cell line.

Authors:  Stewart T Chang; Pavel Sova; Xinxia Peng; Jeffrey Weiss; G Lynn Law; Robert E Palermo; Michael G Katze
Journal:  mBio       Date:  2011-09-20       Impact factor: 7.867

Review 8.  Myristoylation: An Important Protein Modification in the Immune Response.

Authors:  Daniel Ikenna Udenwobele; Ruey-Chyi Su; Sara V Good; Terry Blake Ball; Shailly Varma Shrivastav; Anuraag Shrivastav
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

9.  Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1.

Authors:  Miroslav P Milev; Mukunthan Ravichandran; Morgan F Khan; David C Schriemer; Andrew J Mouland
Journal:  Front Microbiol       Date:  2012-10-25       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.